Dr. Rodney JY Ho, a distinguished professor and is a presidential entrepreneurial fellow of the University of Washington and the Fred Hutchinson Cancer Research Center, is an expert on pharmacology, drug targeting and antiviral therapy. His research intends to improve the therapeutic efficacy and safety of viral and cancer drugs, medical diagnostic agents and vaccines. He is an elected fellow of the American Association for the Advancement of Sciences and the American Association of Pharmaceutical Scientists (AAPS). He studies the relationships between drug target distribution and its relationship to disease development in cancer, AIDS, and neurological disorders. Building on this understanding, he developed systems Approach to Drug Delivery and Targeting. He is known for expertise in bio-therapeutics, lipid-drug and -protein interactions, liposomes, lipid nanoparticles, pharmacokinetics, and the interplay between tissue targets and drug penetration. His research has led to enhanced HIV, cancer, and pain medication potency and safety. In addition, he is an editor of the J Pharmaceutical Sciences, and author the book, “Biotechnology and Biopharmaceuticals: Transforming Proteins and Gene into Drugs.” He received top honors including the Paul Dawson Biotechnology life-time achievement award, and the AAPS Biotechnology Research achievement, one of the highest AAPS’s recognition.
- Current Clinical Projects
- Who We Are